FDA Adverse Event Injury Summary report: N

ARTZ DISPO (SUPARTZ)

MDR report key: 376856 · Received February 19, 2002

Report

Report Number
9612392-2002-00002
Event Type
Injury
Date Received
February 19, 2002
Date of Event
October 30, 2001
Report Date
February 18, 2002
Manufacturer
SEIKAGAKU CORP.
Product Code
MOZ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

ARTHRITIS: THE PATIENT HAS RECEIVED INTRAARTICULAR INJECTION FROM TIME TO TIME FOR DIAGNOSIS OF OSTEOARTHROSIS OF BOTH KNEES FROM 1994. IN 2001, THE PATIENT RECEIVED THE INJECTION (ARTZ DISPO + 1% XYLOCAINE) INTO THE RIGHT KNEE 1 TIME IN JANUARY, 2 TIMES IN FEBRUARY, 1 TIME IN JULY. 1 TIME IN SEPTEMBER AND 2 TIMES IN OCTOBER. AS PAIN OF THE RIGHT KNEE WAS AGGRAVATED LATER IN OCTOBER, THE PATIENT CAME TO THE HOSPITAL. SYNOVIAL FLUID PUNCTURE WAS CONDUCTED AND THE CLINICAL COURSE WAS OBSERVED, BUT THE SYMPTOM WAS NOT MITIGATED (THE SYNOVIAL FLUID WAS YELLOW TRANSPARENT, AND THE RESULT OF CULTURE WAS NEGATIVE [-]). NOV 2001, THE PATIENT WAS ADMITTED TO THE HOSPITAL. A HIGH INFLAMMATORY REACTION WAS OBSERVED FROM BLOOD TEST. ARTHROSCOPY LATER IN NOVEMBER, 2001 SHOWED SYNOVIAL MEMBRANE PROLIFERATION, AND SYNOVECTOMY WAS CONDUCTED. ALTHOUGH TREATMENT WAS CONTINUED THEREAFTER, CONTRACTURE OF THE RIGHT KNEE REMAINED. IN DEC 2001, THE PATIENT WAS DISCHARGED AND THE CLINICAL COURSE WAS OBSERVED THEREAFTER UNTIL THE INFLAMMATORY REACTION TURNED NEGATIVE. IN JAN 2002, THE PATIENT WAS READIMITTED TO THE HOSPITAL AND A WEEK LATER RIGHT TOTAL KNEE REPLACEMENT WAS CONDUCTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ARTZ DISPO (SUPARTZ) SODIUM HYALURONATE MOZ SEIKAGAKU CORP. NA UNK

Patients

Seq Age Sex Outcome Treatment
1 82 YR Hospitalization 2001.| XYLOCAINE (LIDOCAINE HYDROCHLORIDE): 1994 TO